United States Biotechnology & Medical Research

Dermira Inc (DERM)

Track

Track

Ticker: DERM Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Fust Matthew K
Transaction date
Planned sale
Price
298.96
Quantity 47,674 +13.9%
Value US$2,324,751
Fust Matthew K
Transaction date
Planned sale
Price
286.28
Quantity 74,825 +45.4%
Value US$2,630,732
3.8
Fust Matthew K
Transaction date
Sale
Price
8.77
Quantity 6,000 -35.2%
Value US$52,636
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Purchase
Price
8.54
Quantity 23,419 +44.6%
Value US$199,998
Pena Luis C. Chief Development Officer
Transaction date
Sale
Price
8.54
Quantity 23,419 -57.6%
Value US$199,998
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
15.00
Quantity 35,000 -79.7%
Value US$525,000
Fust Matthew K
Transaction date
Planned sale
Price
13.75
Quantity 4,000 -22.2%
Value US$55,000
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned purchase
Price
10.00
Quantity 12,000 +17.8%
Value US$119,951
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned purchase
Price
8.71
Quantity 13,780 +25.6%
Value US$119,998
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned purchase
Price
9.84
Quantity 12,150 +29.2%
Value US$119,586
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned purchase
Price
10.10
Quantity 11,875 +40.0%
Value US$119,954
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
25.00
Quantity 2,500 -47.2%
Value US$62,500
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
25.32
Quantity 500 -15.1%
Value US$12,658
Cohen David E
Transaction date
Planned sale
Price
25.85
Quantity 600 -2.0%
Value US$15,510
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
28.55
Quantity 3,000 -51.7%
Value US$85,642
Cohen David E
Transaction date
Planned sale
Price
28.87
Quantity 600 -1.9%
Value US$17,322
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
28.03
Quantity 100 -3.4%
Value US$2,803
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
27.04
Quantity 2,900 -50.0%
Value US$78,407
Cohen David E
Transaction date
Planned sale
Price
28.03
Quantity 600 -1.9%
Value US$16,818
Griffith Christopher M. SVP Head Corp. Dev. & Strategy
Transaction date
Planned sale
Price
27.91
Quantity 200 -0.5%
Value US$5,581
Griffith Christopher M. SVP Head Corp. Dev. & Strategy
Transaction date
Planned sale
Price
27.04
Quantity 18,258 -29.6%
Value US$493,773
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
27.34
Quantity 3,000 -43.9%
Value US$82,011
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
27.51
Quantity 5,000 -26.8%
Value US$137,566
Cohen David E
Transaction date
Planned sale
Price
25.49
Quantity 600 -1.9%
Value US$15,294
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
27.52
Quantity 5,000 -27.1%
Value US$137,608
Cohen David E
Transaction date
Planned sale
Price
26.82
Quantity 600 -1.8%
Value US$16,092
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
30.04
Quantity 7,500 -21.8%
Value US$225,300
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
27.52
Quantity 5,000 -27.1%
Value US$137,606
Cohen David E
Transaction date
Planned sale
Price
26.99
Quantity 600 -1.8%
Value US$16,194
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
27.51
Quantity 9,500 -41.4%
Value US$261,336
Cohen David E
Transaction date
Planned sale
Price
23.56
Quantity 600 -1.8%
Value US$14,136
Cohen David E
Transaction date
Planned sale
Price
23.81
Quantity 600 -1.7%
Value US$14,286
CRAVES FRED B
Transaction date
Purchase
Price
23.95
Quantity 10,000 +50.0%
Value US$239,460
CRAVES FRED B
Transaction date
Purchase
Price
22.57
Quantity 20,000 +inf%
Value US$451,470
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
27.58
Quantity 500 -6.1%
Value US$13,791
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
30.00
Quantity 2,500 -6.8%
Value US$75,008
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
29.06
Quantity 5,000 -39.4%
Value US$145,298
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
30.01
Quantity 2,500 -6.3%
Value US$75,032
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
27.61
Quantity 1,121 -12.7%
Value US$30,951
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
27.50
Quantity 3,879 -33.5%
Value US$106,672
Griffith Christopher M. SVP Head Corp. Dev. & Strategy
Transaction date
Planned sale
Price
27.07
Quantity 1,312 -2.8%
Value US$35,516
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
33.65
Quantity 2,500 -6.0%
Value US$84,116
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
34.39
Quantity 100 -1.5%
Value US$3,439
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
33.65
Quantity 7,900 -54.6%
Value US$265,833
RINGO WILLIAM R
Transaction date
Planned sale
Price
34.06
Quantity 500 -100.0%
Value US$17,030
Griffith Christopher M. SVP Head Corp. Dev. & Strategy
Transaction date
Planned sale
Price
33.97
Quantity 1,303 -2.8%
Value US$44,267
RINGO WILLIAM R
Transaction date
Planned sale
Price
34.03
Quantity 500 -100.0%
Value US$17,015
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
34.03
Quantity 1,414 -17.9%
Value US$48,118
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
33.38
Quantity 6,586 -45.5%
Value US$219,831
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
34.03
Quantity 521 -1.2%
Value US$17,730
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
33.40
Quantity 1,979 -4.4%
Value US$66,106
Griffith Christopher M. SVP Head Corp. Dev. & Strategy
Transaction date
Planned sale
Price
36.37
Quantity 100 -0.2%
Value US$3,637
Griffith Christopher M. SVP Head Corp. Dev. & Strategy
Transaction date
Planned sale
Price
35.74
Quantity 1,203 -2.6%
Value US$42,993
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
37.60
Quantity 4,000 -38.2%
Value US$150,416
RINGO WILLIAM R
Transaction date
Planned sale
Price
35.09
Quantity 500 -100.0%
Value US$17,547
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
35.89
Quantity 100 -0.2%
Value US$3,589
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
34.49
Quantity 400 -0.9%
Value US$13,795
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
33.81
Quantity 1,200 -2.6%
Value US$40,569
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
32.60
Quantity 800 -1.7%
Value US$26,079
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
35.91
Quantity 272 -4.0%
Value US$9,769
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
35.08
Quantity 600 -8.2%
Value US$21,047
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
33.91
Quantity 4,328 -37.1%
Value US$146,782
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
32.99
Quantity 5,800 -33.2%
Value US$191,347
Griffith Christopher M. SVP Head Corp. Dev. & Strategy
Transaction date
Planned sale
Price
31.38
Quantity 403 -0.9%
Value US$12,646
Griffith Christopher M. SVP Head Corp. Dev. & Strategy
Transaction date
Planned sale
Price
30.52
Quantity 900 -1.9%
Value US$27,472
RINGO WILLIAM R
Transaction date
Planned sale
Price
32.00
Quantity 500 -100.0%
Value US$16,000
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
30.00
Quantity 1,505 -3.1%
Value US$45,153
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
29.99
Quantity 204 -3.1%
Value US$6,118
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
29.33
Quantity 4,796 -41.8%
Value US$140,647
BAUER EUGENE A Chief Medical Officer
Transaction date
Planned sale
Price
30.00
Quantity 995 -2.0%
Value US$29,852
Griffith Christopher M. VP Corp. Dev. & Strategy
Transaction date
Planned sale
Price
30.08
Quantity 200 -0.4%
Value US$6,016
Griffith Christopher M. VP Corp. Dev. & Strategy
Transaction date
Planned sale
Price
28.94
Quantity 1,103 -2.4%
Value US$31,921
WIGGANS THOMAS G CEO & Chairman of the Board
Transaction date
Planned sale
Price
32.51
Quantity 3,000 -31.7%
Value US$97,543
RINGO WILLIAM R
Transaction date
Planned sale
Price
32.00
Quantity 500 -100.0%
Value US$16,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-02-20 2020-02-20 B Purchase
Bald Eagle Acquisition Corp
Large shareholder
1,824 -28.7%
33.60
US$3,735,788 		1,824 -28.7% 33.60 US$3,735,788
2019-12-26 2019-12-24 PlS Planned sale Fust Matthew K
47,674 +13.9%
298.96
US$2,324,751 		47,674 +13.9% 298.96 US$2,324,751
2019-12-13 2019-12-12 PlS Planned sale Fust Matthew K
74,825 +45.4%
286.28
US$2,630,732 		74,825 +45.4% 286.28 US$2,630,732
2019-09-16 2019-09-12 S Sale
3.8
Fust Matthew K
6,000 -35.2%
8.77
US$52,636 		6,000 -35.2% 8.77 US$52,636
2019-08-19 2019-08-19 B Purchase WIGGANS THOMAS G

CEO & Chairman of the Board
23,419 +44.6%
8.54
US$199,998 		23,419 +44.6% 8.54 US$199,998
2019-08-19 2019-08-19 S Sale Pena Luis C.

Chief Development Officer
23,419 -57.6%
8.54
US$199,998 		23,419 -57.6% 8.54 US$199,998
2019-04-09 2019-04-08 PlS Planned sale
BAUER EUGENE A

Chief Medical Officer
35,000 -79.7%
15.00
US$525,000 		35,000 -79.7% 15.00 US$525,000
2018-10-19 2018-10-19 PlS Planned sale Fust Matthew K
4,000 -22.2%
13.75
US$55,000 		4,000 -22.2% 13.75 US$55,000
2018-07-09 2018-07-09 PP Planned purchase WIGGANS THOMAS G

CEO & Chairman of the Board
12,000 +17.8%
10.00
US$119,951 		12,000 +17.8% 10.00 US$119,951
2018-07-02 2018-07-02 PP Planned purchase WIGGANS THOMAS G

CEO & Chairman of the Board
13,780 +25.6%
8.71
US$119,998 		13,780 +25.6% 8.71 US$119,998
2018-06-25 2018-06-25 PP Planned purchase WIGGANS THOMAS G

CEO & Chairman of the Board
12,150 +29.2%
9.84
US$119,586 		12,150 +29.2% 9.84 US$119,586
2018-06-18 2018-06-18 PP Planned purchase WIGGANS THOMAS G

CEO & Chairman of the Board
11,875 +40.0%
10.10
US$119,954 		11,875 +40.0% 10.10 US$119,954
2018-03-06 2018-03-02 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
2,500 -47.2%
25.00
US$62,500 		2,500 -47.2% 25.00 US$62,500
2018-03-02 2018-03-01 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
500 -15.1%
25.32
US$12,658 		500 -15.1% 25.32 US$12,658
2018-03-02 2018-03-01 PlS Planned sale Cohen David E
600 -2.0%
25.85
US$15,510 		600 -2.0% 25.85 US$15,510
2018-02-02 2018-02-01 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
3,000 -51.7%
28.55
US$85,642 		3,000 -51.7% 28.55 US$85,642
2018-02-02 2018-02-01 PlS Planned sale Cohen David E
600 -1.9%
28.87
US$17,322 		600 -1.9% 28.87 US$17,322
2018-01-04 2018-01-02 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
100 -3.4%
28.03
US$2,803 		100 -3.4% 28.03 US$2,803
2018-01-04 2018-01-02 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
2,900 -50.0%
27.04
US$78,407 		2,900 -50.0% 27.04 US$78,407
2018-01-04 2018-01-02 PlS Planned sale Cohen David E
600 -1.9%
28.03
US$16,818 		600 -1.9% 28.03 US$16,818
2018-01-04 2018-01-02 PlS Planned sale Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
200 -0.5%
27.91
US$5,581 		200 -0.5% 27.91 US$5,581
2018-01-04 2018-01-02 PlS Planned sale Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
18,258 -29.6%
27.04
US$493,773 		18,258 -29.6% 27.04 US$493,773
2017-12-20 2017-12-18 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
3,000 -43.9%
27.34
US$82,011 		3,000 -43.9% 27.34 US$82,011
2017-12-15 2017-12-13 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
5,000 -26.8%
27.51
US$137,566 		5,000 -26.8% 27.51 US$137,566
2017-12-05 2017-12-01 PlS Planned sale Cohen David E
600 -1.9%
25.49
US$15,294 		600 -1.9% 25.49 US$15,294
2017-11-03 2017-11-02 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
5,000 -27.1%
27.52
US$137,608 		5,000 -27.1% 27.52 US$137,608
2017-11-03 2017-11-01 PlS Planned sale Cohen David E
600 -1.8%
26.82
US$16,092 		600 -1.8% 26.82 US$16,092
2017-10-13 2017-10-11 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
7,500 -21.8%
30.04
US$225,300 		7,500 -21.8% 30.04 US$225,300
2017-10-11 2017-10-10 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
5,000 -27.1%
27.52
US$137,606 		5,000 -27.1% 27.52 US$137,606
2017-10-03 2017-10-02 PlS Planned sale Cohen David E
600 -1.8%
26.99
US$16,194 		600 -1.8% 26.99 US$16,194
2017-09-19 2017-09-18 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
9,500 -41.4%
27.51
US$261,336 		9,500 -41.4% 27.51 US$261,336
2017-09-05 2017-09-01 PlS Planned sale Cohen David E
600 -1.8%
23.56
US$14,136 		600 -1.8% 23.56 US$14,136
2017-08-29 2017-08-28 PlS Planned sale Cohen David E
600 -1.7%
23.81
US$14,286 		600 -1.7% 23.81 US$14,286
2017-08-14 2017-08-14 B Purchase CRAVES FRED B
10,000 +50.0%
23.95
US$239,460 		10,000 +50.0% 23.95 US$239,460
2017-08-14 2017-08-10 B Purchase CRAVES FRED B
20,000 +inf%
22.57
US$451,470 		20,000 +inf% 22.57 US$451,470
2017-08-02 2017-08-01 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
500 -6.1%
27.58
US$13,791 		500 -6.1% 27.58 US$13,791
2017-07-06 2017-07-05 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
2,500 -6.8%
30.00
US$75,008 		2,500 -6.8% 30.00 US$75,008
2017-07-05 2017-07-03 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
5,000 -39.4%
29.06
US$145,298 		5,000 -39.4% 29.06 US$145,298
2017-06-21 2017-06-20 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
2,500 -6.3%
30.01
US$75,032 		2,500 -6.3% 30.01 US$75,032
2017-06-05 2017-06-02 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
1,121 -12.7%
27.61
US$30,951 		1,121 -12.7% 27.61 US$30,951
2017-06-05 2017-06-01 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
3,879 -33.5%
27.50
US$106,672 		3,879 -33.5% 27.50 US$106,672
2017-05-16 2017-05-15 PlS Planned sale Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
1,312 -2.8%
27.07
US$35,516 		1,312 -2.8% 27.07 US$35,516
2017-05-03 2017-05-01 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
2,500 -6.0%
33.65
US$84,116 		2,500 -6.0% 33.65 US$84,116
2017-05-03 2017-05-01 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
100 -1.5%
34.39
US$3,439 		100 -1.5% 34.39 US$3,439
2017-05-03 2017-05-01 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
7,900 -54.6%
33.65
US$265,833 		7,900 -54.6% 33.65 US$265,833
2017-05-03 2017-05-01 PlS Planned sale RINGO WILLIAM R
500 -100.0%
34.06
US$17,030 		500 -100.0% 34.06 US$17,030
2017-04-18 2017-04-17 PlS Planned sale Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
1,303 -2.8%
33.97
US$44,267 		1,303 -2.8% 33.97 US$44,267
2017-04-04 2017-04-03 PlS Planned sale RINGO WILLIAM R
500 -100.0%
34.03
US$17,015 		500 -100.0% 34.03 US$17,015
2017-04-04 2017-04-03 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
1,414 -17.9%
34.03
US$48,118 		1,414 -17.9% 34.03 US$48,118
2017-04-04 2017-04-03 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
6,586 -45.5%
33.38
US$219,831 		6,586 -45.5% 33.38 US$219,831
2017-04-04 2017-04-03 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
521 -1.2%
34.03
US$17,730 		521 -1.2% 34.03 US$17,730
2017-04-04 2017-04-03 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
1,979 -4.4%
33.40
US$66,106 		1,979 -4.4% 33.40 US$66,106
2017-03-16 2017-03-15 PlS Planned sale Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
100 -0.2%
36.37
US$3,637 		100 -0.2% 36.37 US$3,637
2017-03-16 2017-03-15 PlS Planned sale Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
1,203 -2.6%
35.74
US$42,993 		1,203 -2.6% 35.74 US$42,993
2017-03-07 2017-03-03 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
4,000 -38.2%
37.60
US$150,416 		4,000 -38.2% 37.60 US$150,416
2017-03-02 2017-03-01 PlS Planned sale RINGO WILLIAM R
500 -100.0%
35.09
US$17,547 		500 -100.0% 35.09 US$17,547
2017-03-02 2017-03-01 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
100 -0.2%
35.89
US$3,589 		100 -0.2% 35.89 US$3,589
2017-03-02 2017-03-01 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
400 -0.9%
34.49
US$13,795 		400 -0.9% 34.49 US$13,795
2017-03-02 2017-03-01 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
1,200 -2.6%
33.81
US$40,569 		1,200 -2.6% 33.81 US$40,569
2017-03-02 2017-03-01 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
800 -1.7%
32.60
US$26,079 		800 -1.7% 32.60 US$26,079
2017-03-02 2017-03-01 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
272 -4.0%
35.91
US$9,769 		272 -4.0% 35.91 US$9,769
2017-03-02 2017-03-01 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
600 -8.2%
35.08
US$21,047 		600 -8.2% 35.08 US$21,047
2017-03-02 2017-03-01 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
4,328 -37.1%
33.91
US$146,782 		4,328 -37.1% 33.91 US$146,782
2017-03-02 2017-03-01 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
5,800 -33.2%
32.99
US$191,347 		5,800 -33.2% 32.99 US$191,347
2017-02-16 2017-02-15 PlS Planned sale Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
403 -0.9%
31.38
US$12,646 		403 -0.9% 31.38 US$12,646
2017-02-16 2017-02-15 PlS Planned sale Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
900 -1.9%
30.52
US$27,472 		900 -1.9% 30.52 US$27,472
2017-02-16 2017-02-15 PlS Planned sale RINGO WILLIAM R
500 -100.0%
32.00
US$16,000 		500 -100.0% 32.00 US$16,000
2017-02-15 2017-02-14 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
1,505 -3.1%
30.00
US$45,153 		1,505 -3.1% 30.00 US$45,153
2017-02-03 2017-02-01 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
204 -3.1%
29.99
US$6,118 		204 -3.1% 29.99 US$6,118
2017-02-03 2017-02-01 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
4,796 -41.8%
29.33
US$140,647 		4,796 -41.8% 29.33 US$140,647
2017-02-02 2017-02-01 PlS Planned sale BAUER EUGENE A

Chief Medical Officer
995 -2.0%
30.00
US$29,852 		995 -2.0% 30.00 US$29,852
2017-01-19 2017-01-17 PlS Planned sale Griffith Christopher M.

VP Corp. Dev. & Strategy
200 -0.4%
30.08
US$6,016 		200 -0.4% 30.08 US$6,016
2017-01-19 2017-01-17 PlS Planned sale Griffith Christopher M.

VP Corp. Dev. & Strategy
1,103 -2.4%
28.94
US$31,921 		1,103 -2.4% 28.94 US$31,921
2017-01-05 2017-01-04 PlS Planned sale WIGGANS THOMAS G

CEO & Chairman of the Board
3,000 -31.7%
32.51
US$97,543 		3,000 -31.7% 32.51 US$97,543
2017-01-04 2017-01-04 PlS Planned sale RINGO WILLIAM R
500 -100.0%
32.00
US$16,000 		500 -100.0% 32.00 US$16,000
Explore more

More insider trading research around Dermira Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America